Latest From Biotech Now

Unleashing the Full Promise of Biotechnology Innovation

Jim Greenwood

Last week, I attended the announcement of President Obama’s Precision Medicine Initiative at the White House. In the room were leading biotechnology executives, researchers, lawmakers from both parties, regulatory officials and patients. Seated just a few rows in front of me was a young man named Bill Elder whose life has been transformed by a cystic fibrosis drug developed by one of our member companies, Vertex. Today, Bill is a third-year medical student with an Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,

Does a “non-G.M.O” Label Really Mean without GMOs?

Non gmo verfieid

In her article, Many G.M.O.-Free Labels, Little Clarity Over Rules, Stephanie Strom examines the issues behind food manufacturers adding the phrase “non-G.M.O.” to their packaging without having to go through a verification process: So if more companies elect to put labels on their products stating that they are G.M.O.-free, whether verified or not, does that make the fierce policy debate increasingly moot? “It’s an interesting question,” said Jean Halloran, director of food policy initiatives at Consumers Union, which lobbies Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Measles Outbreak Shows Dangers of Vaccine Misinformation

Vaccination

On Sunday, Centers for Disease Control (CDC) Director Tom Friedan said that the U.S. could be faced with a “large outbreak” of measles, according to the Washington Post. The agency reported that 102 cases of measles were confirmed in 14 states in January. Hundreds of others are being monitored for possible exposure. The majority of the confirmed cases are among patients who have not been vaccinated, illustrating the danger posed to both individual and public Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Deputy General Counsel Remarks on Revised Eligibility Guidance

Supreme Court

Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property recently spoke at the U.S. Patent and Trademark Office’s public forum on patent-eligible subject matter. The forum was a chance for the Office to receive public feedback regarding the most recently revised Eligibility Guidance for determining subject matter under 35 U.S.C. 1010. Biotechnology advocates are concerned that PTO examiners have interpreted recent decisions by the U.S. Supreme Court, including those in Alice Corp, Myriad, and Mayo Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , ,

GMO Answers…well, Answers “What are Some Safety Problems with GMOs?”

GMO-Answers1 copy

GMO Answers recently received the question “What are Some Safety Issues with GMOs?”  Site expert Robert Wager M.Sc., a faculty member in the Biology Department, at Vancouver Island University in Nanaimo, BC, Canada, answered this question below. “When discussing safety of GM crops and derived food it is easier to separate the food safety aspects from the environmental aspects.  This answer will deal with food safety issues. Every GM crop is extensively tested for food Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,